肝细胞癌术后严重并发症发生线上预测模型建立与评价

doi:10.3969/j.issn.1009-976X.2023.04.001

摘要/Abstract

摘要： 目的探讨肝细胞癌（HCC）术后严重并发症发生的高危因素, 并构建线上预测模型以帮助临床医务工作者快速识别高危人群并予以干预措施, 从而促进患者术后早期康复。方法回顾性分析中山大学孙逸仙纪念医院2009年12月至2017年12月347例接受肝癌切除术的HCC患者的临床病历资料, 基于Logistic回归分析明确术后出现严重并发症的高危因素, 并以此为基础构建线上预测模型, 通过一致性指数（C指数）及校正曲线等验证模型预测效能。结果共39例患者术后出现严重并发症, 其术后平均住院时长（19±10）天。经过多因素回归分析提示伴发慢性病, 吸烟酗酒史, 术前血清ALT及GGT水平, 癌灶数目与手术时间是HCC术后出现严重并发症的危险因素（P<0.05）。以多因素分析结果为基础构建线上预测模型。经内部验证, 该预测模型C指数为0.845, 且校正曲线提示该模型具有良好的预测性能。结论 HCC术后严重并发症的发生是围术期死亡的重要原因, 通过本研究所建立的线上预测模型, 临床医务工作者可快速简便识别高危人群并予以干预措施, 可有效缩短术后康复时间。

关键词: 肝细胞癌, 肝癌切除术, 严重并发症, 预测模型

Abstract: Objective To construct and validate an online predictive model of severe postoperative complications for hepatocellular carcinoma （HCC）. Methods The clinical data of 347 HCC patients who underwent resection from December 2009 to December 2017 in Sun Yat-sen Memorial Hospital of Sun Yat-sen University were retrospectively analyzed. The significantly independent factors of severe postoperative complications were identified according to the logistic regression analysis, and then an online model was constructed. A concordance index （C-index） and calibration curve were used to validate the performance and clinical utility of the model. Results A total of 39 cases had severe complications after hepatectomy and the mean postoperative hospital stay was 19±10 days. Multivariate regression analysis suggested that concomitant disease, smoking/drinking, preoperative serum ALT and GGT levels, surgery time, and the number of tumors were risk factors for severe complications （P<0.05）. Based on the results of the multi-factor analysis, an online prediction model was developed. After internal verification, the C-index of the developed model was 0.845. Conclusion Severe postoperative complications tend to increase the risk of perioperative mortality for HCC. Clinicians can figure out those patients at high risk of severe postoperative complications more efficiently by using the constructed model, which can effectively shorten postoperative hospital stay and improve short-term outcomes.

Key words: hepatocellular carcinoma, surgery, severe postoperative complication, predictive model

中图分类号:

R619

黄桂忠, 林巧红, 尹鹏飞, 张建龙. 肝细胞癌术后严重并发症发生线上预测模型建立与评价[J]. 岭南现代临床外科, 2023, 23(04): 289-293.

HUANG Gui-zhong, LIN Qiao-hong, YIN Peng-fei, ZHANG Jian-long. Constructing and validating an online predictive model of severe postoperative complication for hepatocellular carcinoma[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 289-293.

参考文献

[1] 《原发性肝癌诊疗规范(2019年版)》编写专家委员会. 原发性肝癌诊疗规范(2019年版)[J].中国临床医学, 2020, 27(1):140-160.
[2] Marrero JA, Kulik LM, Sirlin CB, et al.Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2018, 68(2): 723-750.
[3] Jarnagin WR, Gonen M, Fong Y, et al.Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade[J]. Ann Surg, 2002, 236(4): 397-406.
[4] Chok KSH, Chan MMY, Dai WC, et al.Survival outcomes of hepatocellular carcinoma resection with postoperative complications-a propensity-score-matched analysis[J]. Medicine (Baltimore), 2017, 96(12): e6430.
[5] 邱洁净, 莫新少, 滕艳娟, 等.肝细胞癌患者肝切除术后严重并发症列线图风险预测模型的建立与评价[J].中国普通外科杂志, 2021, 30(01):24-31.
[6] Donadon M, Fontana A, Palmisano A, et al.Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score[J]. HPB (Oxford), 2017, 19(10): 910-918.
[7] Peng W, Li JW, Zhang XY, et al.A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma[J]. PLoS One, 2019, 14(7): e0219219.
[8] Dindo D, Demartines N, Clavien PA.Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240(2): 205-13.
[9] Ma KW, Cheung TT, She WH, et al.Risk prediction model for major complication after hepatectomy for malignant tumour-A validated scoring system from a university center[J]. Surg Oncol, 2017, 26(4): 446-452.
[10] Zou H, Wen Y, Yuan K, et al.Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients[J]. Liver Int, 2018, 38(3): 494-502.
[11] 殷子, 卢昕, 刘宇斌, 等.腹腔镜下肝切除术后并发症相关危险因素分析[J].消化肿瘤杂志(电子版), 2015, 7(4):204-208.
[12] 刘恒, 李大江, 刘建.肝切除术后并发症相关因素分析[J].中华实用诊断与治疗杂志, 2013, 27(5):426-427.
[13] Uchiyama H, Harimoto N, Itoh S, et al.Pleural Effusion After Hepatectomy for Hepatocellular Carcinoma: Risk Factor Analyses and Its Impact on Oncological Outcomes[J]. World J Surg, 2017, 41(4): 1089-1099.
[14] 陈亚进, 陈捷. 腹腔镜右半肝切除术的技术要领——手术流程的标准化[J]. 中国实用外科杂志, 2017, 37(5):481-485.
[15] 姚兰杰. 原发性胆汁性肝硬化前期及肝硬化期治疗前后肝功能指标水平分析[J].中国现代药物应用, 2014, 8(16):65-66.
[16] 洪江, 刘娟.慢性乙肝合并肝硬化患者血清谷丙转氨酶、乙肝表面抗原水平与肝功能的相关性[J].上海医药, 2015, 36(7):47-49.
[17] Whitfield JB.Gamma glutamyl transferase[J]. Crit Rev Clin Lab Sci, 2001, 38(4):263-355.
[18] Naqvi IH, Talib A, Naqvi SH, et al.The Neuro-Vascular Consequence of Diabetes: Foot Amputation and Evaluation of its Risk Factors and Health-Related Economic Impact[J]. Curr Vasc Pharmacol, 2021, 19(1):102-109.
[19] Pierre S, Rivera C, Le Maître B, et al.Guidelines on smoking management during the perioperative period[J]. Anaesth Crit Care Pain Med, 2017, 36(3): 195-200.